会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明申请
    • METHODS FOR DIAGNOSIS OF CHRONIC PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME
    • 慢性前列腺增生症慢性阻塞性肺疾病诊断方法
    • US20090220994A1
    • 2009-09-03
    • US12393357
    • 2009-02-26
    • Jordan Dimitrakov
    • Jordan Dimitrakov
    • G01N33/53
    • G01N33/6893G01N2800/342
    • The present invention relates to methods for diagnosis of chronic prostatitis/chronic pain pelvic syndrome (CP/CPPS). We have found specific biomarkers that are present in higher concentrations in patients that have chronic prostatitis/chronic pain pelvic syndrome (CP/CPPS) as compared to subjects that have no symptoms of CP/CPPS. In particular, uromodulin (THP), aminopeptidase N (AMPN), dipeptidylpeptidase IV (CD26), neprilysin (NEP), zinc-α-2-glycoprotein (ZA2G) and alkaline phosphatase (ALP) were found to be present at higher concentrations in CP/CPPS patient urine that is voided after prostatic message. Accordingly, the invention is directed to methods for diagnosis of CP/CPPS by monitoring the levels of at least one of these proteins in post-prostatic massage urine, as well as to diagnostic kits designed for diagnosis of CP/CPPS.
    • 本发明涉及慢性前列腺炎/慢性骨盆综合征(CP / CPPS)的诊断方法。 与没有CP / CPPS症状的受试者相比,我们发现具有慢性前列腺炎/慢性骨盆综合征(CP / CPPS)的患者中具有较高浓度的特异性生物标志物。 特别地,发现尿调节素(THP),氨基肽酶N(AMPN),二肽基肽酶IV(CD26),尿丙氨酸(NEP),锌-α-2-糖蛋白(ZA2G)和碱性磷酸酶(ALP) CP / CPPS患者尿液在前列腺消息后失效。 因此,本发明涉及通过监测前列腺前列腺按摩尿中至少一种蛋白质的水平以及为诊断CP / CPPS而设计的诊断试剂盒来诊断CP / CPPS的方法。